Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $34

SVB Leerink analyst Joseph Schwartz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and raises the price target from $33 to $34.
byBenzinga Newsdesk
February 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Joseph Schwartz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and raises the price target from $33 to $34.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0